Skip to main content
. 2019 Feb 22;2(2):e190115. doi: 10.1001/jamanetworkopen.2019.0115

Figure 2. Association of Gene Polymorphism in HSD3B1 rs1047303 With Sensitivity and Prognosis in Cases With Castration-Resistant Prostate Cancer Treated With Abiraterone.

Figure 2.

A, Waterfall plots showing the greatest decline in prostate-specific antigen (PSA) values from baseline during abiraterone treatment in 97 men whose PSA response were available. B and C, Treatment failure–free survival rate (B) and overall survival rate (C) stratified by gene polymorphism in HSD3B1 rs1047303 are shown.

aStatistically significant.